These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30767764)

  • 1. SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments.
    Qin M; Li H; Bao J; Xia Y; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Shu X; Wang X
    Acta Neuropathol Commun; 2019 Feb; 7(1):21. PubMed ID: 30767764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
    Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
    Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
    Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
    Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
    Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.
    Hu W; Wang Z; Zhang H; Mahaman YAR; Huang F; Meng D; Zhou Y; Wang S; Jiang N; Xiong J; Westermarck J; Lu Y; Wang J; Wang X; Shentu Y; Liu R
    Neurotherapeutics; 2022 Mar; 19(2):570-591. PubMed ID: 35286657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
    Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
    Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.
    Chasseigneaux S; Clamagirand C; Huguet L; Gorisse-Hussonnois L; Rose C; Allinquant B
    BMC Neurosci; 2014 Jun; 15():82. PubMed ID: 24981783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
    Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
    Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
    Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
    J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease.
    Zhao J; Li X; Chen X; Cai Y; Wang Y; Sun W; Mai H; Yang J; Fan W; Tang P; Ou M; Zhang Y; Huang X; Zhao B; Cui L
    J Cell Physiol; 2019 Jul; 234(7):10411-10420. PubMed ID: 30511419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
    Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
    Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α Causes LCMT1/PP2A Deficiency and Mediates Tau Hyperphosphorylation and Cognitive Dysfunction during Chronic Hypoxia.
    Lei L; Feng J; Wu G; Wei Z; Wang JZ; Zhang B; Liu R; Liu F; Wang X; Li HL
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice.
    Zhou Y; Yang D; Chen H; Zheng C; Jiang H; Liu X; Huang X; Ye S; Song S; Jiang N; Zhao Z; Ma S; Ma J; Huang K; Chen C; Fan X; Gong Y; Wang X; Fan J; Liu R; Shentu Y
    FASEB J; 2020 Dec; 34(12):16414-16431. PubMed ID: 33070372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus.
    Zhang CE; Tian Q; Wei W; Peng JH; Liu GP; Zhou XW; Wang Q; Wang DW; Wang JZ
    Neurobiol Aging; 2008 Nov; 29(11):1654-65. PubMed ID: 17537547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
    Arif M; Kazim SF; Grundke-Iqbal I; Garruto RM; Iqbal K
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1144-9. PubMed ID: 24395787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.
    Yu G; Yan T; Feng Y; Liu X; Xia Y; Luo H; Wang JZ; Wang X
    Neurobiol Aging; 2013 Jul; 34(7):1748-58. PubMed ID: 23374587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.